The interactions of MK-801 with the amphetamine analogues D-methamphetamine (D-METH), 3,4-methylenedioxymethamphetamine (D-MDMA) or D-fenfluramine (D-FEN): neural damage and neural protection.
Miller
D B
DB
United States Environmental Protection Agency, Health Effects Research Laboratory, Research Triangle Park, North Carolina 27711.
O'Callaghan
J P
JP
D015104:3,4-Methylenedioxyamphetamine / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000633:toxicity; D000818:Animals; D015415:Biomarkers; D001921:Brain / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D016291:Dizocilpine Maleate / Q000494:pharmacology*; D005260:Female; D005277:Fenfluramine / Q000037:antagonists & inhibitors / Q000633:toxicity*; D005904:Glial Fibrillary Acidic Protein / Q000032:analysis / Q000378:metabolism*; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D008694:Methamphetamine / Q000037:antagonists & inhibitors / Q000633:toxicity*; D051379:Mice; D008810:Mice, Inbred C57BL; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D009498:Neurotoxins / Q000037:antagonists & inhibitors / Q000633:toxicity*
D015415:Biomarkers; D005904:Glial Fibrillary Acidic Protein; D009498:Neurotoxins; D005277:Fenfluramine; D008694:Methamphetamine; D015104:3,4-Methylenedioxyamphetamine; D016291:Dizocilpine Maleate; D018817:N-Methyl-3,4-methylenedioxyamphetamine